FR2264530A1 - N-(heterocyclyl)substd benzamides - with antiemetic activity, also useful in treating psychic disorders and migraine - Google Patents

N-(heterocyclyl)substd benzamides - with antiemetic activity, also useful in treating psychic disorders and migraine

Info

Publication number
FR2264530A1
FR2264530A1 FR7509371A FR7509371A FR2264530A1 FR 2264530 A1 FR2264530 A1 FR 2264530A1 FR 7509371 A FR7509371 A FR 7509371A FR 7509371 A FR7509371 A FR 7509371A FR 2264530 A1 FR2264530 A1 FR 2264530A1
Authority
FR
France
Prior art keywords
substd
benzamides
migraine
heterocyclyl
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7509371A
Other languages
English (en)
French (fr)
Other versions
FR2264530B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Antonio Gallardo SA
Original Assignee
Antonio Gallardo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB12572/74A external-priority patent/GB1507462A/en
Application filed by Antonio Gallardo SA filed Critical Antonio Gallardo SA
Publication of FR2264530A1 publication Critical patent/FR2264530A1/fr
Application granted granted Critical
Publication of FR2264530B1 publication Critical patent/FR2264530B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
FR7509371A 1974-03-21 1975-03-20 N-(heterocyclyl)substd benzamides - with antiemetic activity, also useful in treating psychic disorders and migraine Granted FR2264530A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB12572/74A GB1507462A (en) 1974-03-21 1974-03-21 N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
GB3540274 1974-08-12

Publications (2)

Publication Number Publication Date
FR2264530A1 true FR2264530A1 (en) 1975-10-17
FR2264530B1 FR2264530B1 (enExample) 1978-11-10

Family

ID=26249107

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7509371A Granted FR2264530A1 (en) 1974-03-21 1975-03-20 N-(heterocyclyl)substd benzamides - with antiemetic activity, also useful in treating psychic disorders and migraine

Country Status (11)

Country Link
JP (1) JPS584019B2 (enExample)
AR (1) AR216043A1 (enExample)
CH (1) CH602641A5 (enExample)
DK (1) DK147854C (enExample)
ES (5) ES435753A1 (enExample)
FI (1) FI60200C (enExample)
FR (1) FR2264530A1 (enExample)
KE (1) KE2900A (enExample)
NL (1) NL159660B (enExample)
NO (1) NO144108C (enExample)
SE (1) SE427750B (enExample)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2705949A1 (de) * 1976-02-17 1977-08-25 Gallardo Antonio Sa Neue therapeutika auf piperidinbasis
FR2387955A1 (fr) * 1977-04-22 1978-11-17 Beecham Group Ltd Derives de l'aniline utilisables comme medicament
FR2446274A1 (fr) * 1979-01-15 1980-08-08 Delalande Sa Nouveaux derives de salicylamide, leur procede de preparation et leur application en therapeutique
EP0343307A1 (en) * 1988-05-26 1989-11-29 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. 4-Piperidinealkanamine derivatives
EP0507672A1 (fr) * 1991-04-02 1992-10-07 LABORATOIRES JACQUES LOGEAIS Société dite: Dérivés de N-cyclohexyl benzamides, leurs préparations et leurs applications en thérapeutique
FR2766484A1 (fr) * 1997-07-25 1999-01-29 Logeais Labor Jacques Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse
FR2766486A1 (fr) * 1997-07-25 1999-01-29 Logeais Labor Jacques Cycloalkyles benzamides stimulants de la motricite gastrointestinale haute et basse
EP2786986A4 (en) * 2011-11-29 2015-01-14 Vivozon Inc NEW BENZAMIDE DERIVATIVES AND APPLICATION THEREOF

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006128803A1 (en) * 2005-06-02 2006-12-07 F. Hoffmann-La Roche Ag Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
KR100976063B1 (ko) * 2007-03-16 2010-08-17 동아제약주식회사 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2705949A1 (de) * 1976-02-17 1977-08-25 Gallardo Antonio Sa Neue therapeutika auf piperidinbasis
FR2387955A1 (fr) * 1977-04-22 1978-11-17 Beecham Group Ltd Derives de l'aniline utilisables comme medicament
FR2446274A1 (fr) * 1979-01-15 1980-08-08 Delalande Sa Nouveaux derives de salicylamide, leur procede de preparation et leur application en therapeutique
EP0343307A1 (en) * 1988-05-26 1989-11-29 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. 4-Piperidinealkanamine derivatives
EP0507672A1 (fr) * 1991-04-02 1992-10-07 LABORATOIRES JACQUES LOGEAIS Société dite: Dérivés de N-cyclohexyl benzamides, leurs préparations et leurs applications en thérapeutique
FR2674849A1 (fr) * 1991-04-02 1992-10-09 Logeais Labor Jacques Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
US5273983A (en) * 1991-04-02 1993-12-28 Laboratories Jacques Logeais Cyclohexylbenzamide derivatives, their preparations and their use as gastrointestinal stimulants
FR2766484A1 (fr) * 1997-07-25 1999-01-29 Logeais Labor Jacques Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse
FR2766486A1 (fr) * 1997-07-25 1999-01-29 Logeais Labor Jacques Cycloalkyles benzamides stimulants de la motricite gastrointestinale haute et basse
WO1999005133A1 (fr) * 1997-07-25 1999-02-04 Laboratoires Jacques Logeais Cycloalkyles benzamides stimulants de la motricite gastrointestinale haute et basse
EP2786986A4 (en) * 2011-11-29 2015-01-14 Vivozon Inc NEW BENZAMIDE DERIVATIVES AND APPLICATION THEREOF
US9359346B2 (en) 2011-11-29 2016-06-07 Vivozon, Inc. Benzamide derivative and use thereof

Also Published As

Publication number Publication date
NL7503417A (nl) 1975-09-23
DK147854C (da) 1985-07-22
ES435753A1 (es) 1977-04-01
NO144108B (no) 1981-03-16
JPS584019B2 (ja) 1983-01-24
ES435754A1 (es) 1977-04-01
NO144108C (no) 1981-06-24
FR2264530B1 (enExample) 1978-11-10
CH602641A5 (enExample) 1978-07-31
NL159660B (nl) 1979-03-15
DK117675A (enExample) 1975-09-22
AR216043A1 (es) 1979-11-30
FI60200B (fi) 1981-08-31
NO750957L (enExample) 1975-09-23
SE427750B (sv) 1983-05-02
DK147854B (da) 1984-12-24
ES435756A1 (es) 1977-04-01
KE2900A (en) 1978-12-01
SE7503196L (enExample) 1975-09-22
ES435757A1 (es) 1977-04-01
FI750825A7 (enExample) 1975-09-22
FI60200C (fi) 1981-12-10
JPS50129573A (enExample) 1975-10-13
ES435755A1 (es) 1977-04-01

Similar Documents

Publication Publication Date Title
FR2264530A1 (en) N-(heterocyclyl)substd benzamides - with antiemetic activity, also useful in treating psychic disorders and migraine
IE41856L (en) Heterocyclyl thioureas and guanidines
CA2066640A1 (en) Heterocyclic compounds
ATE246171T1 (de) Aminosulfonylcarbamate
DE3570079D1 (en) Thienylthiazole compounds
IE33021B1 (en) New guanylhydrazones and process for their manufacture
CA2124680A1 (en) Piperazine derivatives as 5-ht1a antagonists
EP0175376A3 (en) Xanthone derivatives and process for producing the same
IE40570B1 (en) Benzylamine derivatives and process for preparing them
DE3587596D1 (de) Pyridazinon-Derivate, deren Herstellung und Verwendung.
ES449740A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-(benzazolilalquil) piperidina.
KR850000755B1 (en) Process for preparing 3,1-benzoxazin-2-ones and acid addition salts thereof
HUT37797A (en) Process for production of tetrahydro-tieno-piridinderivatives and medical preparatives containing of such compounds
SE7603051L (sv) Pyrimidinylkarbamider
EG17621A (en) Novel crystalline form of benzotiazine dioxide salt
RO83439B (ro) Procedeu pentru repararea n-cian-n'-metil-n"-(2-((5metil-1h-imidazol-4-il)-metil)-tio)-etil-guanidinei
NO159018C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive disubstituerte polymetyleniminer.
DE3363740D1 (en) 3-pyridyl-5-alkoxy-(or phenoxy- or aralkyloxy-)pyrazole derivatives, process for their preparation, and their therapeutical use
ES8700235A1 (es) Procedimiento para la obtencion de nuevos derivados de la piperidina
FI853868L (fi) Pyridinderivat, foerfarande foer framstaellning av dessa och farmaceutiska foereningar innehaollande dessa.
JPS5370100A (en) Production of fibrous hydrous alkali calcium silicate
ES450299A1 (es) Un procedimiento de fabricacion de nuevos compuestos quimi- cos derivados de n-pinolidin-2-etilamina.
ATE25584T1 (de) Verwendung von gamma-piperidino-butyrophenonen zu herstellung von arzneimitteln zum behandeln von diarrhoee.
FR2244518A1 (en) N-sinapyl-N'-alkoxyalkyl or-aminocarbonylmethyl-piperazines - as vasodilators, diuretics, antihypertensive and antiulcer agents
FR2323383A1 (fr) Nouveaux derives de 5-thiazole methane amine, un procede pour leur preparation, leur application a titre de medicaments

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name